These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Multicentre, double-blind, crossover trial to identify the Optimal Pathway for TreatIng neurOpathic paiN in Diabetes Mellitus (OPTION-DM): study protocol for a randomised controlled trial. Selvarajah D, Petrie J, White D, Julious S, Bortolami O, Cooper C, Bradburn M, Loban A, Bowler H, Swaby L, Sutherland K, Tesfaye S, OPTION-DM group. Trials; 2018 Oct 22; 19(1):578. PubMed ID: 30348206 [Abstract] [Full Text] [Related]
10. Amitriptyline, Pregabalin and Duloxetine for Treatment of Painful Diabetic Peripheral Neuropathy. Nepal R, Bajracharya MR, Karki BB, Mall D, Shrestha PS, Wasti KP, Bisht A. J Nepal Health Res Counc; 2024 Jun 22; 22(1):185-191. PubMed ID: 39080958 [Abstract] [Full Text] [Related]
11. Duloxetine for the treatment of painful diabetic peripheral neuropathy in Venezuela: economic evaluation. Carlos F, Espejel L, Novick D, López R, Flores D. Medwave; 2015 Sep 25; 15(8):e6265. PubMed ID: 26460688 [Abstract] [Full Text] [Related]
12. Amitriptyline, Duloxetine, and Pregabalin Each Effective in Decreasing Pain From Diabetic Peripheral Neuropathy; Combinations Even Better. Barry HC. Am Fam Physician; 2023 Mar 25; 107(3):316-317. PubMed ID: 36920835 [No Abstract] [Full Text] [Related]
17. The Treatment of Painful Diabetic Neuropathy. Sloan G, Alam U, Selvarajah D, Tesfaye S. Curr Diabetes Rev; 2022 May 25; 18(5):e070721194556. PubMed ID: 34238163 [Abstract] [Full Text] [Related]
18. Management of diabetic neuropathy. Cernea S, Raz I. Metabolism; 2021 Oct 25; 123():154867. PubMed ID: 34411554 [Abstract] [Full Text] [Related]